UC San Francisco’s Health eHeart Study – an ambitious technology-based cardiovascular research study – has garnered the support from the American Heart Association, the largest U.S. non-profit organization dedicated to reducing disability and deaths caused by cardiovascular disease and stroke.
December 06, 2013
January 17, 2013
The risk of kidney failure is greater for people with chronic kidney disease who also have atrial fibrillation, one of the most common forms of irregular heart rhythm in adults, according to a new study by researchers at UCSF and the Kaiser Permanente Northern California Division of Research.
November 06, 2012
Hospitalized heart failure patients who received the drug, serelaxin, in a phase III clinical trial had fewer disease symptoms and as a group experienced 37 percent fewer deaths over six months, according to results of a new study.
August 16, 2012
It’s become common practice for the roughly 6 million Americans per year who go to emergency rooms with chest pain: Get a stress test or cardiac CT (computed tomography) scan before discharge.
August 08, 2012
Depression was linked with an increased risk of peripheral artery disease (PAD) in a study of more than 1,000 men and women with heart disease conducted by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
May 14, 2012
What is the connection, if any, between sudden cardiac death and people with HIV/AIDS? And can that knowledge help prolong their lives?
April 18, 2012
Scientists at the UCSF-affiliated Gladstone Institutes announced a research breakthrough in mice that one day may help doctors restore hearts damaged by heart attacks — by converting scar-forming cardiac cells into beating heart muscle.
April 10, 2012
Can a simple diagnostic test used to measure a heart’s electrical activity help predict heart attacks? And can that knowledge help doctors reroute their patients away from coronary heart disease?
November 04, 2011
UCSF was recently recognized as a 2011 gold-level recipient of the American Heart Association’s Start! Fit-Friendly Companies Recognition program.
September 19, 2011
A UCSF study holds clues to why an emerging clinical trials option for heart attack patients has not been as successful as anticipated. Treatment of human hearts with bone marrow cells has led to limited to no success in improving their heart function even though a similar method has been much more effective in rodents.